CHU Saint-Antoine

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Colorectal cancer1 trial
• Liver and biliary tract cancer1 trial
• Multiple sclerosis1 trial

Phase

• Phase 21 trial
• Phase 2/31 trial

Status

• Active, not recruiting1 trial
• Completed1 trial
• Not yet recruiting1 trial

Lead sponsor

• EDMUS Foundation1 trial
• Federation Francophone de Cancerologie Digestive1 trial
• GERCOR - Multidisciplinary Oncology Cooperative Group1 trial

Running trials

• Not yet recruiting

  BETWEEN: Biweekly Bevacizumab + Trifluridine/Tipiracil to Reduce Grade 3-4 Neutropenia in mCRC Patients

  NCT07071844· Phase 2· GERCOR - Multidisciplinary Oncology Cooperative Group· Source

  Contact: Romain Cohen, MD

• Active, not recruiting

  OFSEP High Definition Cohort

  NCT03603457· EDMUS Foundation· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer1 recruiting

Closed trials

• Completed

  Study Evaluating the Benefit of Adding Ipilimumab to the Combination of Atezolizumab and Bevacizumab in Patients With Hepatocellular Carcinoma Receiving First-line Systemic Therapy

  NCT05665348· Phase 2/3· Federation Francophone de Cancerologie Digestive· Source